Chromosome engineering of Escherichia coli for constitutive production of salvianic acid A

Abstract

BackgroundSalvianic acid A (SAA), a valuable natural product from herbal plant Salvia miltiorrhiza, exhibits excellent antioxidant activities on food industries and efficacious therapeutic potential on cardiovascular diseases. Recently, production of SAA in engineered Escherichia coli was established via the artificial biosynthetic pathway of SAA on the multiple plasmids in our previous work. However, the plasmid-mediated system required to supplement expensive inducers and antibiotics during the fermentation process, restricting scale-up production of SAA. Microbial cell factory would be an attractive approach for constitutive production of SAA by chromosome engineering.ResultsThe limited enzymatic reactions in SAA biosynthetic pathway from glucose were grouped into three modules, which were sequentially integrated into chromosome of engineered E. coli by λ Red homologous recombination method. With starting strain E. coli BAK5, in which the ptsG, pykF, pykA, pheA and tyrR genes were previously deleted, chassis strain BAK11 was constructed for constitutive production of precursor l-tyrosine by replacing the 17.7-kb mao-paa cluster with module 1 (PlacUV5-aroG fbr-tyrA fbr-aroE) and the lacI gene with module 2 (Ptrc-glk-tktA-ppsA). The synthetic 5tacs promoter demonstrated the optimal strength to drive the expression of hpaBC-d-ldh Y52A in module 3, which then was inserted at the position between nupG and speC on the chromosome of strain BAK11. The final strain BKD13 produced 5.6 g/L of SAA by fed-batch fermentation in 60 h from glucose without any antibiotics and inducers supplemented.ConclusionsThe plasmid-free and inducer-free strain for SAA production was developed by targeted integration of the constitutive expression of SAA biosynthetic genes into E. coli chromosome. Our work provides the industrial potential for constitutive production of SAA by the indel microbial cell factory and also sets an example of further producing other valuable natural and unnatural products.Electronic supplementary materialThe online version of this article (doi:10.1186/s12934-017-0700-2) contains supplementary material, which is available to authorized users.

Expanding the repertoire of aromatic chemicals by microbial production

“…The final engineered strain E. coli BKD13 produced 5.6 g L −1 of salvianic acid A by fed-batch fermentation in 60 h from glucose without any antibiotics and inducers. 71 HpaBC also can convert L-Tyr into L-DOPA, which is an aromatic pharmaceutical employed for the treatment of Parkinson's disease. Munoz et al 72 reported the construction of an E. coli strain with the metabolic capacity for production of L-DOPA from glucose and speculated that the conversion of L-Tyr into L-DOPA catalyzed by HpaBC may be the rate-limiting step.…”

Context‐dependency of synthetic minimal promoters in driving gene expression: a case study

“…These promoters have the potential to be independent of the endogenous transcription regulation and function more robustly than those naturally derived ones (Gilman and Love, 2016;Portela et al, 2017). Some synthetic promoters such as the J231 family in the Registry of Standard Biological Parts have gained wide application in gene circuit construction (Qi et al, 2012), tool development (Jervis et al, 2019), chemical production (Meng et al, 2016;Choi et al, 2017;Zhou et al, 2017) and the characterization of biological systems (Pasotti et al, 2012). However, inconsistencies in their transcriptional strength and responses to environmental signals are often encountered (Pasotti et al, 2012;Kosuri et al, 2013;Zucca et al, 2015;Jervis et al, 2019), for which promoters exhibiting high activities in certain conditions might become the weak ones under another context.…”

Enhancing the bioconversion of phytosterols to steroidal intermediates by the deficiency of kasB in the cell wall synthesis of Mycobacterium neoaurum

“…It usually takes 120 to 144 h to realize a satisfactory conversion rate of the substrate to target steroid intermediates in the microbes [5,6,25]. However, it only takes about 48 to 72 h in most of other prokaryotic microorganisms [26][27][28]. The long conversion time is primarily attributed to the low permeability of sterol substrates into the cell wall [2].…”